We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
SUMO | Summit Minerals Ltd | 0.022 | 0.011 | 100.00% | 975,852 | 20 |
JAV | Javelin Minerals Ltd | 0.002 | 0.001 | 100.00% | 726,024 | 6 |
LSR | Lodestar Minerals Limited | 0.002 | 0.001 | 100.00% | 300,680 | 4 |
CT1 | Constellation Technologies Limited | 0.002 | 0.001 | 100.00% | 77,945 | 2 |
OZM | OzAurum Resources Limited | 0.072 | 0.024 | 50.00% | 2,197,182 | 93 |
NGS | Nutritional Growth Solutions Ltd | 0.006 | 0.002 | 50.00% | 1,792,729 | 13 |
WTM | Waratah Minerals Ltd | 0.14 | 0.035 | 33.33% | 457,225 | 35 |
WMG | Western Mines Group Ltd | 0.42 | 0.105 | 33.33% | 2,306,171 | 421 |
MGUO | Magnum Mining and Exploration Ltd | 0.004 | 0.001 | 33.33% | 750,000 | 1 |
IS3 | I Synergy Group Limited | 0.004 | 0.001 | 33.33% | 6,941,183 | 16 |
CG1 | Carbonxt Group Limited | 0.074 | 0.0175 | 30.97% | 382,808 | 13 |
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has accepted its New Drug Submission (NDS) for trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Health Canada has granted Priority Review for Acadia’s submission.
Pilot plant produces qualification samples for strategic customers and demonstrates commercial maturity of internally-developed production process RENO, Nev., April 22, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, announced the completion of construction and start of commissioning of its lithium hydroxide (LiOH) pilot plant marking a significant milestone in the commercialization of its internally-developed processes to access an unrealized domestic primary lithium resource.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,636.20 | 225.64 | 0.34% | 1.31T | 3,033,238,126 |
ETH | Ethereum | 3,253.63 | 33.16 | 1.03% | 390.47B | 1,770,052,603 |
USDT | Tether USD | 0.99991 | -0.00008 | -0.01% | 97.84B | 388,012,617 |
BNB | Binance Coin | 608.62 | 2.43 | 0.40% | 96B | 477,864,836 |
SOL | Solana | 158.04 | 3.43 | 2.22% | 69.58B | 1,164,535,290 |
STETH | stETH | 3,237.80 | 19.59 | 0.61% | 31.73B | 2,126,481 |
XRP | Ripple | 0.5501 | 0.0054 | 0.99% | 29.97B | 382,852,067 |
USDC | USD Coin | 0.9998 | -0.0001 | -0.01% | 28.07B | 1,122,813,576 |
DOGE | Dogecoin | 0.16237 | 0.00251 | 1.57% | 23.09B | 405,787,829 |
TONCOIN | Wrapped TON Coin | 5.87 | 0.167708 | 2.94% | 20.33B | 145,441,654 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions